# Dianthus Therapeutics, Inc.: Form 8-K, filed Mar 21, 2024

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: 8-K
- Filed: 2024-03-21
- Accepted by EDGAR: Mar 21, 2024, 16:04 ET
- Period: 2024-03-21
- Accession: 0000950170-24-034667
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000095017024034667/dnth-20240321.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000095017024034667/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000095017024034667/dnth-20240321.htm

Filed Mar 21, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-034667. Last ingested by Listed: Oct 30, 2026, 11:27 ET. No prices; not investment advice.